“Cognitive enhancement drugs only have short-term benefits and can cause significant side-effects for people with mild memory problems, according to researchers. In a new review of existing data, researchers at St. Michael’s Hospital in Toronto, Canada studied eight randomized clinical trials and three companion reports on the efficacy of four drugs in people with mild cognitive impairment. The drugs were donepezil (Aricept), rivastigmine (Exelon), galantamine (Razadyne), and memantine (Namenda). They found that while the drugs do have short-term benefits, they are lost after a year and a half of treatment.”
Did you like this?
Tip Freedomwat.ch Staff with Bitcoin
Tip Freedomwat.ch Staff with Bitcoin
Related posts:
Australian Mining Companies Are Desperate For Workers And Want To Hire US Veterans
Carlyle Jumps Into Niche Space: Trailer Parks
Even when jobs return, Detroit’s workers fall short on skills
MSNBC's Alex Wagner vs. Ron Paul On Syria, Liberty, Anti-Semitism
TSA issued $1.8 million in airport firearms fines last year
Unilever sees 'return to poverty' in Europe
Ex-CIA agent convicted of Italian kidnapping and held in Panama being returned to US
€250,000 strapped to German pensioner's genitals seized at border
Washington Sees Incomes Soar as Most of U.S. Declines
Somali American caught up in a shadowy Pentagon counterpropaganda campaign
Multiple Canadians denied entry to U.S. based on phone searches
China promises bank rescue in next crisis
French mother jailed for sending son to school in ‘I am a bomb’ shirt
India finance minister to countrymen: Contain 'uncontrolled passion' for gold
Polish $300 Billion Aid Package Hides EU Expansion Flaws